Understanding Drivers of Ocular Fibrosis: Current and Future Therapeutic Perspectives
Ocular fibrosis leads to severe visual impairment and blindness worldwide, being a major area of unmet need in ophthalmology and medicine. To date, the only available treatments are antimetabolite drugs that have significant potentially blinding side effects, such as tissue damage and infection. The...
Enregistré dans:
Auteurs principaux: | Fabiana Mallone, Roberta Costi, Marco Marenco, Rocco Plateroti, Antonio Minni, Giuseppe Attanasio, Marco Artico, Alessandro Lambiase |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/cb71e9d22f7f40b3b57e8b81fe01434e |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Ocular lubricant use in medically and surgically treated glaucoma: a retrospective longitudinal analysis
par: Iyer JV, et autres
Publié: (2017) -
Trends in the characteristics of vitrectomy in Eastern China
par: Fang Y, et autres
Publié: (2018) -
Current Situation and Prospect of Teleophthalmology
par: ZHANG Xiao, et autres
Publié: (2021) -
Macular pigment optical density: repeatability, intereye correlation, and effect of ocular dominance
par: Davey PG, et autres
Publié: (2016) -
Patient considerations in ocular hypertension: role of bimatoprost ophthalmic solution
par: Lee D, et autres
Publié: (2017)